Kristin S. Bramlage, MD

Longitudinal performance of vibration controlled transient elastography in pediatric metabolic dysfunction associated steatotic liver disease. Diop-West, N; Denson, N; Arce-Clachar, AC; Bonn, J; Bramlage, K; Leesman, L; Sahay, RD; Gecili, E; Trout, AT; Xanthakos, S; Mouzaki, M. Journal of Pediatric Gastroenterology and Nutrition. 2026.

Reclassifying pediatric NAFLD using the steatotic liver disease framework: A multicenter retrospective study from the NASH CRN. Lam, TBN; Yates, KP; Noon, SL; Newton, KP; Fishbein, MH; Molleston, JP; Xanthakos, SA; Jain, AK; Vos, MB; Blondet, NM; Mysore, KR; Behling, CA; Wilson, LA; Schwimmer, JB. Hepatology. 2025.

Elevated Alpha-Fetoprotein Levels in Children with Metabolic Dysfunction-Associated Liver Disease. Klein, J; Arce-Clachar, AC; Bramlage, K; Xanthakos, S; Sheridan, R; Mouzaki, M. Childhood Obesity. 2025; 21(6):544-548.

Least significant change with repeat bioelectrical impedance analysis measurements in children with metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. Speakman, A; Hitchcock, K; Romantic, E; Quiambao, V; Lepolt, A; Arce-Clachar, AC; Bramlage, K; Fei, L; Sun, Q; Xanthakos, S; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2025; 49(2):200-206.

Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease. Speakman, A; Hitchcock, K; Romantic, E; Quiambao, V; Lepolt, A; Ley, S; Arce-Clachar, AC; Bramlage, K; Fei, L; Sun, Q; Xanthakos, S; Mouzaki, M. Journal of Pediatrics. 2025; 276:114301.

Food Insecurity and Pediatric Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Zhao, X; Setchell, KDR; Carr, E; Arce-Clachar, AC; Bramlage, K; Huang, R; Fei, L; Beck, AF; Fawaz, R; Valentino, PL; Xanthakos, SA; Mouzaki, M. Journal of Pediatrics. 2024; 265:113818.

Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease. P V Alves, V; T Trout, A; Dewit, M; Mouzaki, M; Arce-Clachar, AC; S Bramlage, K; R Dillman, J; A Xanthakos, S. Childhood Obesity. 2023; 19(7):461-469.

Presence of Alpha 1 Antitrypsin Risk Variants is Not Associated With Histologic Severity of Pediatric NAFLD. Khan, M; Klepper, C; Orkin, S; Arce-Clachar, AC; Bramlage, K; Fei, L; Miethke, A; Kohli, R; Xanthakos, S; Mouzaki, M. Journal of Pediatric Gastroenterology and Nutrition. 2023; 77(2):166-170.

Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease. Khurana, T; Klepper, C; Fei, L; Sun, Q; Bramlage, K; Arce-Clachar, AC; Xanthakos, S; Mouzaki, M. Journal of Pediatrics. 2022; 250:61-66.e1.

Insight Into the Adolescent Patient Experience With Nonalcoholic Fatty Liver Disease. Ley, SL; Kidwell, KM; Van Dyk, TR; Orkin, S; Odar Stough, C; Howarth, T; Goetz, AR; Xanthakos, SA; Bramlage, K; Mouzaki, M; Arce-Clachar, AC; Zeller, MH. Journal of Pediatric Gastroenterology and Nutrition. 2022; 75(1):88-96.